1. Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Modern Pathology. 2018;31(12):1770-1786.
2. Guadagno E, De Rosa G,Del Basso De Caro M. Neuroendocrine tumours in rare sites: differences in nomenclature and diagnostics-a rare and ubiquitous histotype. J Clin Pathol. 2016;69(7):563-574.
3. Margolis B, Tergas AI, Chen L, et al.Natural history and outcome of neuroendocrine carcinoma of the cervix. Gynecol Oncol. 2016;141(2):247-254.
4. Sitthinamsuwan P, Angkathunyakul N, Chuangsuwanich T, Inthasorn P. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study. J Med Assoc Thai. 2013;96(1):83-90.
5. Howitt BE, Kelly P, McCluggage WG. Pathology of neuroendocrine tumours of the female genital tract. Curr Oncol Rep. 2017;19(9):59.
6. Tempfer CB, Tischoff I, Dogan A, et al. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.BMC Cancer. 2018;18(1):530.
7. Emerson RE, Michael H, Wang M, Zhang S, Roth LM, Cheng L. Cervical carcinomas with neuroendocrine differentiation: Areport of 28 cases with immunohistochemical analysis and molecular genetic evidence of common clonal origin with coexisting squamous and adenocarcinomas. Int J GynecolPathol. 2016;35(4):372-384.
8. Gadducci A, Carinelli S, Aletti G. Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists. Gynecol Oncol. 2017;144(3):637-646.
9. Bermúdez A, Vighi S, Garcı´a A, Sardi J. Neuroendocrine cervical carcinoma: A diagnostic and therapeutic challenge. Gynecol Oncol. 2001;82(1):32-39.
10. Fadiloglu E, Karalok A, Turkmen O, et al. Amphricrine carcinoma of the cervix-adenoneuroendocrine tumor: A case report. Turk J Obstet Gynecol. 2016;13(2):99-102.
11. Hara H, Ishii E, Hondo T, Nakagawa M, Teramoto K, Oyama T. Cytological features of atypical carcinoid combined with adenocarcinoma of the uterine cervix. DiagnCytopathol.2012;40(8):724-728.
12. Nishimura C, Naoe H, Hashigo S, et al. Pancreatic metastasis from mixed adenoneuroendocrine carcinoma of the uterine cervix: a case report. Case Rep Oncol. 2013;6(2):256-262.
13. Ramalingam P, Malpica A, Deavers MT. Mixed endocervical adenocarcinoma and high-grade neuroendocrine carcinoma of the cervix with ovarian metastasis of the former component: a report of 2 cases.Int J GynecolPathol. 2012;31(5):490-496.
14. Horn LC, Hentschel B, Bilek K, Richter CE, Einenkel J, Leo C. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index. Ann Diagn Pathol. 2006;10(3):140-143.
15. Lee SI, Atri M. 2018 FigO staging system for uterine cervical cancer: Enter cross-sectional imaging. Radiology. 2019;292(1):15-24.
16. Sodsanrat K, Saeaib N, Liabsuetrakul T. Comparison of clinical manifestations and survival outcomes between neuroendocrine tumor and squamous cell carcinoma of the uterine cervix: Results from a tertiary center in southern Thailand. J Med Assoc Thai. 2015;98(8):725-733.
17. Wang KL, Yang YC, Wang TY, et al. Neuroendocrine carcinoma of the uterine cervix: A clinicopathologic retrospective study of 31 cases with prognostic implications. J Chemother. 2006;18(2):209-216.
18. Castle PE, Pierz A, Stoler MH. A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix.Gynecol Oncol. 2018;148(2):422-429.
19. Small W Jr, Bacon MA, Bajaj A, et al.Cervicalcancer: A global health crisis. Cancer. 2017;123(13):2404-2412.
20. Holl K, Nowakowski AM, Powell N, et al. Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study. Int J Cancer. 2015;137(12):2858-2868.
21. Missaoui N, Mestiri S, Bdioui A, et al. HPV infection and p16INK4A and TP53 expression in rare cancers of the uterine cervix. Pathol Res Pract. 2018;214(4):498-506.
22. Horn LC, Lindner K, Szepankiewicz G, et al. p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.Int J GynecolPathol. 2006;25(2):182-186.
23. Salvo G, Gonzalez Martin A, Gonzales NR, Frumovitz M. Updates and management algorithm for neuroendocrine tumors of the uterine cervix.Int J Gynecol Cancer. 2019;29(6):986-995.
24. Cavalcanti MS, Schultheis AM, Ho C, et al. Mixed mesonephric adenocarcinoma and high-grade neuroendocrine carcinoma of the uterine cervix. Int J GynecolPathol.2017;36(1):76-89.
25. Mikami Y, McCluggage WG. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.AdvAnatPathol.2013;20(4):227-237.
26. Xue Y, San Luis B, Lane DP. Intratumour heterogeneity of p53 expression; causes and consequences. J Pathol. 2019;249(3):274-285.
27. Muraoka S, Takahashi T, Ando M, Nishikawa Y, Fujita M, Shimoda A. Minute carcinoid tumor of the uterine cervix associated with microinvasive adenocarcinoma, with reference to its histogenesis. Acta PatholJpn. 1987;37(7):1183-1198.
28. Gaur P, Sceusi EL, Samuel S, et al. Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology. 2011;141(5):1728-1737.
29. Sukpan K, Settakorn J, Khunamornpong S, Cheewakriangkrai C, Srisomboon J, Siriaunkgul S. Expression of survivin, CD117, and C-erbB-2 in neuroendocrine carcinoma of the uterine cervix. Int J Gynecol Cancer. 2011;21(5):911-917.
30. Sheets EE, Berman ML, Hrountas CK, Liao SY, DiSaia PJ. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol. 1988;71(1):10-14.
31. Wang KL, Yang YC, Wang TY, et al. Neuroendocrine carcinoma of the uterine cervix: A clinicopathologic retrospective study of 31 cases with prognostic implications. J Chemother. 2006;18(2):209-216.
32. Abeler VM, Holm R, Nesland JM, Kjørstad KE. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients.Cancer. 1994;73(3):672-677.
33. Păun I, Becheanu G, Costin AI, et al. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system-a review.Rom J MorpholEmbryol. 2018;59(3):673-678.
34. La Rosa S, Marando A, Sessa F, Capella C. Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update. Cancers (Basel). 2012;4(1):11-30.
35. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004;93(1):27-33